Good to see my position is getting closer to green :)
I think we'll see the top line release on Monday or Tuesday of next week. I'm looking for a solid results. I'm not expecting the numbers to be the same as the initial data from this summer. If we see any meaningful spread between the placebo arm and the active arm it should result in the company's first partnership and a floor to the stock price.
It's critical to remember that IPIX is going after prevention of OM not just duration. This is a big market and if a swish and spit solution is proven to work the uptake will be impressive. Once approved, who knows what other off label indications could be treated and I wouldn't be supprised if this didn't turn into a 1+B/yr revenue drug.
I think we're very close to 3rd party verification that the technology is real and partnership funds will follow which will reduce pressure on the BS.
Market Data 
Markets 
AI
